Daily pill daraxonrasib doubles survival time for pancreatic cancer patients
- Posted on June 1, 2026
- By BBC News
- 0 Views
- 1 min read
Daily pill daraxonrasib doubles survival time for pancreatic cancer patients
The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.